Literature DB >> 2003052

Evidence of infection with organisms producing Shiga-like toxins in household contacts of children with the hemolytic uremic syndrome.

E L Lopez1, M Diaz, S Devoto, S Grinstein, M Woloj, B E Murray, E Rubeglio, F Mendilaharzu, M Turco, M Vasquez.   

Abstract

We conducted a prospective study in 87 household contacts of 51 children with hemolytic uremic syndrome to determine the frequency of infection with Shiga-like toxin-producing bacteria. Gastrointestinal tract symptoms occurred in only 1 of 87 contacts. Free fecal toxin was detected in 25 of 64 (39%) of the household members. Neutralization with specific antisera to Shiga-like toxins I and II (SLT-I, SLT-II) revealed that in 6 of these household contacts only SLT-I was present in stool, in 10 only SLT-II was present and in 9 both toxins were found. Thirty-three percent of the hemolytic uremic syndrome families in which 2 or more members were studied had more than 1 household member with free fecal toxin in stool. None of the household contacts was found to have E. coli O157:H7 in feces. Serum samples were available in 77 household contacts; 75% (58 of 77) had serum neutralizing titers of greater than or equal to 1:4 to 1 or both toxins. In those contacts for whom paired sera were available, seroconversion was found in 10 of 24 (42%). These data show that household contacts of children with hemolytic uremic syndrome are commonly colonized with Shiga-like toxin-producing E. coli and seroconversion to Shiga-like toxins occurs frequently in family members of children with hemolytic uremic syndrome.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2003052     DOI: 10.1097/00006454-199101000-00005

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  13 in total

1.  Indirect hemagglutination assay for diagnosis of Escherichia coli O157 infection in patients with hemolytic-uremic syndrome.

Authors:  M Bitzan; H Karch
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

2.  Shiga toxin-producing Escherichia coli infection and antibodies against Stx2 and Stx1 in household contacts of children with enteropathic hemolytic-uremic syndrome.

Authors:  Kerstin Ludwig; Volkan Sarkim; Martin Bitzan; Mohamed A Karmali; Christoph Bobrowski; Hans Ruder; Rainer Laufs; Ingo Sobottka; Martin Petric; Helge Karch; Dirk E Müller-Wiefel
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

3.  Oral administration of Shiga toxin-producing Escherichia coli induces intestinal and systemic specific immune response in mice.

Authors:  Romina Jimena Fernandez-Brando; Gabriel Cabrera; Ariela Baschkier; María Pilar Mejías; Cecilia Analia Panek; Elizabeth Miliwebsky; María Jimena Abrey-Recalde; Leticia Verónica Bentancor; María Victoria Ramos; Marta Rivas; Marina Sandra Palermo
Journal:  Med Microbiol Immunol       Date:  2014-01-08       Impact factor: 3.402

4.  Prognosis of motor development and joint hypermobility.

Authors:  E Tirosh; M Jaffe; R Marmur; Y Taub; Z Rosenberg
Journal:  Arch Dis Child       Date:  1991-08       Impact factor: 3.791

5.  Neutralizing antibodies to Escherichia coli Vero cytotoxin 1 and antibodies to O157 lipopolysaccharide in healthy farm family members and urban residents.

Authors:  D Reymond; R P Johnson; M A Karmali; M Petric; M Winkler; S Johnson; K Rahn; S Renwick; J Wilson; R C Clarke; J Spika
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

6.  Haemolytic-uraemic syndrome in childhood: surveillance and case-control studies in Italy. Italian HUS Study Group.

Authors:  A Gianviti; F Rosmini; A Caprioli; R Corona; M C Matteucci; F Principato; I Luzzi; G Rizzoni
Journal:  Pediatr Nephrol       Date:  1994-12       Impact factor: 3.714

7.  In vitro activity of azithromycin against bacterial enteric pathogens.

Authors:  M E Gordillo; K V Singh; B E Murray
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

8.  Intracellular activity of azithromycin against bacterial enteric pathogens.

Authors:  R M Rakita; K Jacques-Palaz; B E Murray
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

9.  Shiga toxin-producing Escherichia coli in household members of children with hemolytic uremic syndrome.

Authors:  Laura Fernanda Alconcher; Marta Rivas; Lucas Ivan Lucarelli; Jimena Galavotti; Mabel Rizzo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-11-28       Impact factor: 3.267

10.  Typing of group A streptococci by random amplified polymorphic DNA analysis.

Authors:  H Seppälä; Q He; M Osterblad; P Huovinen
Journal:  J Clin Microbiol       Date:  1994-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.